Bausch Health Companies | VRX - Operating Profit



Bausch Health Companies reported $457M in Operating Profit for its fiscal quarter ending in June of 2025.


Operating Profit Change Date
Amgen USD 2.66B 1.37B Jun/2025
ANI Pharmaceuticals USD 15.17M 11.02M Jun/2025
Aurora Cannabis CAD -20220000 56.44M Jun/2025
Bausch Health Companies USD 457M 181M Jun/2025
Biogen USD 851.8M 540.6M Jun/2025
Bristol-Myers Squibb USD 3.77B 366M Jun/2025
Canopy Growth CAD -22080000 1.74M Jun/2025
Corcept Therapeutics USD 26.67M 23.26M Jun/2025
Danaher USD 760M 523M Jun/2025
Drreddys Laboratories INR 16.84B 1.88B Jun/2025
Eli Lilly USD 7.02B 1.61B Jun/2025
Gilead Sciences USD 2.7B 467M Jun/2025
Novo Nordisk 34.08B 4.71B Jun/2025
Pacira USD 10.23M 8.24M Jun/2025
Perrigo USD 55.6M 23.8M Jun/2025
Prestige Brands USD 71.76M 16.67M Jun/2025
Supernus Pharmaceuticals USD 12.14M 14.74M Jun/2025
Vertex Pharmaceuticals USD 1.15B 123.1M Jun/2025
Zoetis USD 1.02B 205M Jun/2025